4
Scottish Medicines Consortium (SMC) decisions For Singulair® chewable tablets
Pediatric patients 2 to 5 years of age
Generic name: Montelukast Chewable
Montelukast 5 mg Chewable Tablet contains aspartame and sodium Aspartame is
Label: MONTELUKAST SODIUM tablet, chewable MONTELUKAST
Montelukast sodium is a hygroscopic, optically active, white to off-white powder
MONTELUKAST SODIUM- montelukast tablet, chewable MONTELUKA view full title
4 CONTRAINDICATIONS
Available as montelukast sodium; dosage expressed in terms of montelukast
Take it as directed on the prescription label at the same time every day
4)
Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 2
It works by decreasing inflammation in the airways, making it easier to breathe
The following doses are recommended: For adults and adolescents 15 years of age and older: one 10-mg tablet
2 mg montelukast sodium, respectively, which are equivalent to 4 and 5 mg of montelukast, respectively
Both chewable tablets contain the following inactive ingredients: mannitol, microcrystalline cellulose, hydroxypropyl cellulose, red ferric oxide, croscarmellose
Prevent asthma attacks and for the long-term treatment of asthma in adults and children
View montelukast information, including dose, uses, side-effects, pregnancy, breast feeding, (SMC) decisions For Singulair® chewable tablets
Other side effects not listed may also occur in some patients
4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following
Montelukast sodium chewable tablets, 4 mg (montelukast) are light pink to pink colored, speckled oval shaped, biconvex tablets debossed with ‘R’ on one side and ‘593’ on the other side
12 to 23 months: One sachet of 4 mg oral granules once a day
Pediatric Patients 6 to 14 years of age
Compared with placebo, treatment with one 5-mg montelukast sodium chewable tablet daily resulted in a significant improvement in mean morning FEV 1 percent change from baseline (8
There was a significant decrease in the mean